Circle Pharma, Inc. research brief

CIK 1684286 Copy CIK

Generated Nov. 15, 2026, 5:27 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: SOUTH SAN FRANCISCO California. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Jan. 10, 2025 · D/A · 0001684286-25-000001 · Source evidence

  Reported offering amount: 117374782 USD. Reported amount sold: 92444167 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Circle Pharma, Inc. research brief,” CIK 1684286, retrieved Nov. 15, 2026, 5:27 a.m.. Cite the specific accessions used. No amounts have been summed.